SCHEMBL29469657

SCHEMBL29469657

CCOc1ccccc1S(=O)(=O)NC(=O)c1cc2ccc(N3CC4(COC4)C3)cc2o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.41
TP53 P04637 2/20 0.36
RAB9A P51151 5/20 0.36
NPC1 O15118 4/20 0.36
POLB P06746 2/20 0.36
LMNA P02545 5/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
THRB P10828 1/20 0.36
MAPT P10636 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TSHR P16473 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
HTR1A P08908 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24334435 0.94 GAA (0.41) GAATP53RAB9ANPC1POLB
SCHEMBL29469699 0.92 GAA (0.40) GAATP53RAB9ANPC1POLB
SCHEMBL24334306 0.92 GAA (0.42) GAARAB9ANPC1POLBLMNA
SCHEMBL24333686 0.91 GAA (0.41) GAATP53RAB9ANPC1POLB
SCHEMBL24333671 0.90 GAA (0.41) GAATP53RAB9ANPC1POLB
SCHEMBL24334441 0.88 MAPT (0.48) GAATP53RAB9ANPC1POLB
SCHEMBL24334232 0.87 NPC1 (0.46) GAATP53RAB9ANPC1POLB
SCHEMBL24334431 0.86 GAA (0.40) GAATP53RAB9ANPC1POLB
SCHEMBL24333782 0.85 GAA (0.41) GAATP53RAB9ANPC1LMNA
SCHEMBL24334290 0.85 GAA (0.41) GAATP53RAB9ANPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP claimed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed